Page 2 - Best Chemotherapy for lung cancer doctors: TOP 38 doctors

Specialized in medical oncology with 27 years of experience of experience – Dr. Ozden focuses on personalized lung cancer treatment.

• Trained at Istanbul University's Cerrahpaşa Faculty of Medicine
• Medical oncology subspecialty from Kocaeli University
• Served as an internal medicine specialist for 27 years of experience
• Currently practices at VM Medical Park Pendik Hospital

Professor Cicin brings over 29 years of experience of specialized experience in medical oncology, focusing on lung cancer treatment at İstinye University Liv Hospital Topkapı.

• Fellowship-trained in medical oncology at Trakya University
• Professor at Trakya University Faculty of Medicine
• Extensive experience in chemotherapy protocols
• Military hospital background adds unique perspective

Assoc. Prof. Ayse Irem Yasin specializes in lung cancer treatment at Medipol Acibadem District Hospital, with international training and ESMO certification.

• Fellowship-trained in medical oncology at Bezmialem Vakıf University
• ESMO Board Certified – recognized European oncology standard
• International observerships at leading cancer centers in Italy and the US
• Associate professor with academic and clinical expertise

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı, with extensive research and clinical expertise in lung cancer treatment.

• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Published multiple studies on lung cancer outcomes and treatment efficacy
• Specializes in personalized chemotherapy protocols for lung cancer patients

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Raj Nagarkar has performed 50,000+ cancer surgeries, specializing in Breast and Thoracic Surgical Oncology at HCG Manavata Cancer Centre.

• 30 years of experience of surgical oncology experience
• Trained at Tata Memorial Hospital and Royal College of Surgeons
• Involved in 200+ clinical trials
• Professor for DNB Superspecialty Surgical Oncology
• Focus on improving patients' quality of life

Dr. Shaunak presented research on stomach cancer at the elite Gastrointestinal Cancer Symposium by ASCO. He specializes in targeted therapies and the molecular basis of cancer.

• Completed DNB in Medical Oncology from Indraprastha Apollo Hospital
• Senior Residency in Internal Medicine at Shyam Shah Medical College
• Registrar in Medical Oncology at Jawaharlal Nehru Cancer Hospital
• Delivered lectures at International Winter School of Oncology

Dr. Lalit has performed over 10,000 major surgeries, with a focus on minimally invasive cancer surgeries for excellent outcomes.

• Fellowship in Surgical Oncology at Tata Medical Centre, Kolkata
• Specializes in gastrointestinal cancer surgeries
• Co-principal investigator in multiple original research studies
• Assistant Professor at State Cancer Institute and Government Cancer Hospital
• Known for patient-friendly and ethical approach

Dr. Shaikh specializes in organ preservation and functional rehabilitation for oral cancer patients, ensuring quality of life.

• 15 years of experience of experience in Surgical Oncology
• Expertise in major maxillofacial and head & neck surgeries
• Fellowship-trained in Head & Neck Surgical Oncology
• Focused on preventive oral hygiene and early diagnosis
• Researcher with multiple publications in the field

Dr. Shruti Kate specializes in lung cancer treatment and presented her research at the World Conference on Lung Cancer in Toronto – a solo recipient of India's travel award.

• Trained at Tata Memorial Hospital – a leading cancer center
• Expertise in immunotherapy and metronomic therapy for advanced cancers
• Member of ASCO, ESMO, and IASCLC – top oncological societies
• Treats all solid tumors, including lung and breast cancers

Handled more than 30,000 PET scans and 1,000 thyroid cancer patients – Dr. Borde brings extensive nuclear medicine expertise to lung cancer care.

• 11 years of experience of experience in nuclear medicine
• Specializes in PET-CT scans and radioiodine therapies
• Published papers in various medical journals
• Works at HCG Manavata Cancer Centre

Dr. Sridhar P.S. is a radiation oncologist with specialized training in radiotherapy for lung cancer treatment.

• Over 30 years of experience of experience in radiation oncology
• Trained in radiotherapy at Banaras Hindu University
• Diplomate of National Board in radiotherapy
• Member of several prestigious oncology societies